Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand.
Saved in:
| Title: | Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand. |
|---|---|
| Authors: | Chepulis, Lynne1 (AUTHOR) Lynnec@waikato.ac.nz, Rodrigues, Mark1 (AUTHOR), Gan, Han2 (AUTHOR), Keenan, Rawiri1 (AUTHOR), Kenealy, Tim3 (AUTHOR), Murphy, Rinki3,4 (AUTHOR), Karu, Leanne Te3 (AUTHOR), Scott-Jones, Jo5 (AUTHOR), Clark, Penny6 (AUTHOR), Moffitt, Allan7 (AUTHOR), Mustafa, Sara1 (AUTHOR), Lawrenson, Ross1 (AUTHOR), Paul, Ryan1,8 (AUTHOR) |
| Source: | BMC Health Services Research. 3/27/2025, Vol. 25 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14726963 |
|---|---|
| DOI: | 10.1186/s12913-025-12601-3 |
